"La Clinique du Parc à Castelnau-le-Lez (34) est un établissement médico-chirurgical ouvert à tous. Elle rassemble sur plus de 20 000m² les spécialités et plateaux techniques permettant une approche complète de votre problème de santé. Près de 200 médecins et chirurgiens spécialisés assurent une prise en charge globale et pluridisciplinaire (consultations libérales, hospitalisation, urgences). Le laboratoire d'analyse biomédicale ainsi que le centre d'imagerie médicale viennent compléter cette offre, rendant accessible, rapidement, la réalisation des bilans complémentaires requis par votre état de santé. La Clinique du Parc fait partie du Groupe Clinipole, acteur majeur des soins privés en Occitanie."

During the past decade, Clinique du Parc conducted 18 clinical trials. In the 10-year time frame, 18 clinical trials started and 2 clinical trials were completed, i.e. on average, 11.1% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 1 clinical trials were completed. i.e. 16.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Clinique du Parc" #1 sponsor was "Intergroupe Francophone du Myelome" with 4 trials, followed by "The Lymphoma Academic Research Organisation" with 3 trials sponsored, "Boehringer Ingelheim" with 2 trials sponsored, "Centre Hospitalier Universitaire de Saint Etienne" with 2 trials sponsored and "Intergroupe Francophone de Cancerologie Thoracique" with 2 trials sponsored. Other sponsors include 7 different institutions and companies that sponsored additional 17 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Clinique du Parc" #1 collaborator was "Bristol-Myers Squibb" with 2 trials as a collaborator, "Ministry of Health, France" with 2 trials as a collaborator, "Amgen" with 1 trials as a collaborator, "Centre Henri Becquerel" with 1 trials as a collaborator and "Centre Hospitalier Universitaire, Amiens" with 1 trials as a collaborator. Other collaborators include 7 different institutions and companies that were collaborators in the rest 17 trials.

According to Clinical.Site data, the most researched conditions in "Clinique du Parc" are "Multiple Myeloma" (4 trials), "Acute Myeloid Leukemia (AML)" (1 trials), "Advanced Non Small Cell Lung Cancer" (1 trials), "Anticoagulants" (1 trials) and "C-CURVE , Cervical Interbody Cage" (1 trials). Many other conditions were trialed in "Clinique du Parc" in a lesser frequency.

Most popular intervention types in "Clinique du Parc" are "Drug" (13 trials), "Device" (3 trials), "Other" (3 trials) and "Procedure" (3 trials). Other intervention types were less common.

The name of intervention was led by "Rituximab" (2 trials), "4 blood samples" (1 trials), "ASCT" (1 trials), "Antiplatelet therapy (AP)" (1 trials) and "Apixaban 5 MG" (1 trials). Other intervention names were less common.

The vast majority of trials in "Clinique du Parc" are 25 trials for "All" genders.

Currently, there are NaN active trials in "Clinique du Parc". 1 are not yet recruiting, 4 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 13 completed trials in Clinique du Parc, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Clinique du Parc, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 5 trials that are defined as “Not Applicable".

Clinique du Parc has several departments that took part in Clinical trials: "Clinique Du Parc; Hematologie" - 2 trials